Correction: Reducing phenolic off-flavors through CRISPR-based gene editing of the FDC1 gene in Saccharomyces cerevisiae x Saccharomyces eubayanus hybrid lager beer yeasts
Authors:
Stijn Mertens; Brigida Gallone; Jan Steensels; Beatriz Herrera-Malaver; Jeroen Cortebeek; Robbe Nolmans; Veerle Saels; Valmik K. Vyas; Kevin J. Verstrepen
Published in the journal:
PLoS ONE 14(10)
Category:
Correction
doi:
https://doi.org/10.1371/journal.pone.0224525
There are errors in the Funding statement. The correct Funding statement is as follows: The research reported in this article was supported by grants to KJV from Vlaams Instituut voor Biotechnologie (VIB), European Molecular Biology Organization Young Investigator Programme (EMBO YIP), and a European Research Council (ERC) Consolidator Grant CoG682009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Zdroje
1. Mertens S, Gallone B, Steensels J, Herrera-Malaver B, Cortebeek J, Nolmans R, et al. (2019) Reducing phenolic off-flavors through CRISPR-based gene editing of the FDC1 gene in Saccharomyces cerevisiae x Saccharomyces eubayanus hybrid lager beer yeasts. PLoS ONE 14(1): e0209124. https://doi.org/10.1371/journal.pone.0209124 30625138
Článok vyšiel v časopise
PLOS One
2019 Číslo 10
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Těžké menstruační krvácení může značit poruchu krevní srážlivosti. Jaký management vyšetření a léčby je v takovém případě vhodný?
- Profylaxe infekční endokarditidy ve stomatologii
Najčítanejšie v tomto čísle
- Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
- Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
- Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)
- Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis
Zvýšte si kvalifikáciu online z pohodlia domova
Všetky kurzy